Androgen Receptor-Positive Salivary Duct Carcinoma: A Disease Entity With Promising New Treatment Options

被引:127
作者
Jaspers, Heidy C. J. [1 ]
Verbist, Berit M. [1 ,2 ]
Schoffelen, Rafke [1 ]
Mattijssen, Vera [3 ]
Slootweg, Piet J. [1 ]
van der Graaf, Winette T. A. [1 ]
van Herpen, Carla M. L. [1 ]
机构
[1] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands
[2] Leiden Univ, Med Ctr, Leiden, Netherlands
[3] Rijnstate Hosp Arnhem, Arnhem, Netherlands
关键词
CISPLATIN COMBINATION CHEMOTHERAPY; GLAND CARCINOMA; PHASE-II; THERAPY; DOXORUBICIN; CYCLOPHOSPHAMIDE; EXPRESSION; MALIGNANCIES; CANCERS; TUMORS;
D O I
10.1200/JCO.2010.32.8351
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:E473 / E476
页数:4
相关论文
共 30 条
[1]   CISPLATIN, EPIRUBICIN AND 5-FLUOROURACIL COMBINATION CHEMOTHERAPY FOR RECURRENT CARCINOMA OF THE SALIVARY-GLAND [J].
AIROLDI, M ;
PEDANI, F ;
BRANDO, V ;
GABRIELE, P ;
GIORDANO, C .
TUMORI, 1989, 75 (03) :252-256
[2]   CHEMOTHERAPY FOR RECURRENT SALIVARY-GLAND MALIGNANCIES - EXPERIENCE OF THE ENT DEPARTMENT OF TURIN-UNIVERSITY [J].
AIROLDI, M ;
BRANDO, V ;
GIORDANO, C ;
GABRIELE, P ;
BUSSI, M ;
CORTESINA, G .
ORL-JOURNAL FOR OTO-RHINO-LARYNGOLOGY AND ITS RELATED SPECIALTIES, 1994, 56 (02) :105-111
[3]  
CREAGAN ET, 1988, CANCER-AM CANCER SOC, V62, P2313, DOI 10.1002/1097-0142(19881201)62:11<2313::AID-CNCR2820621110>3.0.CO
[4]  
2-4
[5]   FLUOROURACIL, DOXORUBICIN, CYCLOPHOSPHAMIDE, AND CISPLATIN COMBINATION CHEMOTHERAPY IN ADVANCED OR RECURRENT SALIVARY-GLAND CARCINOMA [J].
DIMERY, IW ;
LEGHA, SS ;
SHIRINIAN, M ;
HONG, WK .
JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (06) :1056-1062
[6]  
DREYFUSS AI, 1987, CANCER-AM CANCER SOC, V60, P2869, DOI 10.1002/1097-0142(19871215)60:12<2869::AID-CNCR2820601203>3.0.CO
[7]  
2-Y
[8]   Expression of androgen receptor and prostatic specific markers in salivary duct carcinoma - An immunohistochemical analysis of 13 cases and review of the literature [J].
Fan, CY ;
Wang, JZ ;
Barnes, EL .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2000, 24 (04) :579-586
[9]   HER2 expression in salivary gland carcinomas: Dependence on histological subtype [J].
Glisson, B ;
Colevas, AD ;
Haddad, R ;
Krane, J ;
El-Naggar, A ;
Kies, M ;
Costello, R ;
Summey, C ;
Arquette, M ;
Langer, C ;
Amrein, PC ;
Posner, M .
CLINICAL CANCER RESEARCH, 2004, 10 (03) :944-946
[10]  
Guzzo M, 1997, HEAD NECK-J SCI SPEC, V19, P126, DOI 10.1002/(SICI)1097-0347(199703)19:2<126::AID-HED7>3.0.CO